Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
LONG-TERM OUTCOMES OF INTRAVITREAL BEVACIZUMAB THERAPY FOR SUBRETINAL NEOVASCULARIZATION SECONDARY TO IDIOPATHIC MACULAR TELANGIECTASIA TYPE 2
PaperCitations, authors & open-access status
LONG-TERM OUTCOMES OF INTRAVITREAL BEVACIZUMAB THERAPY FOR SUBRETINAL NEOVASCULARIZATION SECONDARY TO IDIOPATHIC MACULAR TELANGIECTASIA TYPE 2 is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 24 citations, 2016 year and closed oa status.
24
Citations
2016
Year
closed
OA Status